Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methodological study of acute sexual desire changes and single-dose testosterone in women with hypoactive sexual desire disorder
NL-OMON30937Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of testosterone in hypoactive sexual desire disorder (HSDD) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Sexual desire level, Implicit task performance and 4 more. Planned start Nov 2007; status: not yet recruiting.
02
Drugs
testosterone
03
Conditions
hypoactive sexual desire disorder (HSDD)
Beyond the preview
Go deeper on NL-OMON30937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON30937.